Navigation Links
Knee Osteoarthritis More Painful for Smokers: Study

Knee osteoarthritis, which causes inflammation and loss of cartilage in joints, is likely to be more painful for smokers, say US scientists. //

Researchers led by David Felson, a professor at the Boston University Medical School, studied 159 men with symptomatic osteoarthritis of the knee for 30 months. Twelve percent of the participants were current smokers, reported the online edition of BBC News.

The researchers found that smokers had a progressive form of the disease and suffered higher levels of pain.

Magnetic resonance imaging (MRI) scans of the knee showed that the smokers had a two-fold higher risk of cartilage loss in knee joints - a process that occurs as the disease progresses.

Men who smoked also had more pain than those who didn't smoke throughout the study.

Osteoarthritis is much more common in women but there were too few female smokers in the study to measure the effect on them.

However, Felson said the results would probably be the same for women. "There is no reason for it to be different in women as I don't think biology is likely to be different. But we can't be sure."

"It's an additional reason to stop smoking as it may lessen the pain and rate of cartilage loss," he added.

Osteoarthritis - degenerative arthritis - is caused by the breakdown and loss of cartilage in one or more joints.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. New device for discerning Osteoarthritis
2. Osteoarthritis and Estrogen are connected
3. Hyaluronan supplementation therapy for Knee Osteoarthritis
4. Leech Therapy for Osteoarthritis
5. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Pain Relief For Osteoarthritis Patients
8. The Use Of Ointments For The Treatment Of Osteoarthritis Questioned
9. New Drug Found To Benefit Patients With Osteoarthritis
10. Water Exercise Found to be Effective for Patients with Osteoarthritis
11. Hydrotherapy Could Be Effective For Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: